Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UC Research Examines Eugenics Past and Present, Driven by Race, Class, Economics

10.11.2011
UC historian Wendy Kline will present her case study research on coercive birth control used as a form of eugenics. She will present that research at an international conference in Europe on Nov. 11.

Eugenics – the science of improving the human population via selective breeding or reproduction – is not a concept confined to past centuries and decades, nor to locales outside the United States.

That’s the finding of recent research by University of Cincinnati historian Wendy Kline, who will present a case study on the topic – a case study that examines the use of the controversial contraceptive injection, Depo-Provera, as a eugenic tool – on Nov. 11 at a conference titled “The Study of Eugenics: Past, Present and Future” to be held in Uppsala, Sweden. Her presentation is titled “Bodies of Evidence: Activists, Patients, and the FDA Regulation of Depo-Provera.”

It’s research that is particularly timely given that recent national news coverage has featured North Carolina’s current plans to compensate surviving victims of forced sterilizations that took place there from the 1920s to the 1970s.

UC HISTORIAN'S CASE STUDY ON 1983 DEPO-PROVERA HEARINGS
Kline’s research into the debate surrounding Depo-Provera in the 1970s and 1980s began when she was visiting the Smith College Women’s History Archive where she found a large box of materials still unprocessed and not yet catalogued. This was among 50 to 60 boxes from the National Women’s Health Network.

She recalled, “The box contained hundreds of individual files, each detailing a woman’s difficulties with the side effects of Depo-Provera or detailing how she had not been informed of those side effects or detailing how she had been given the injection without her consent or by means of manipulation. This coercion, lack of informed consent and testing of the drug has obviously been gathered together in preparation for a class-action suit by the National Women’s Health Network that had never gone forward.”

But the collection did provide Kline with a rich source of material of examining the history of this contraceptive and the U.S. Food and Drug Administration’s public board of inquiry on Depo-Provera held in 1983.

“The use of Depo-Provera captures all of the controversy of this century regarding controlling fertility and who’s ultimately making the decision about who gets to reproduce. My research looks at coercion, risks not fully understood and how arguments were made for and against Depo-Provera at the time,” she explained.

For instance, it was in the Depo-Provera hearings in Washington that the manufacturer and those in favor of the drug had to first contend with the greater organizational powers and force of the feminist movement – but where that feminist movement had to argue its case by focusing narrowly on the flaws in the scientific research methodology applied when testing Depo-Provera.

In other words, those combating the use of Depo-Provera could not make a case against the drug based on morality or sentiment even though it could easily have been argued that this was a case of eugenics since the testing of the drug in the 1970s at Atlanta’s Grady Memorial Hospital Family Planning Clinic involved mostly black women in public assistance.

Instead, because of FDA strictures related to evidence supplied at its board of inquiry hearings, opponents of the drug had to channel their arguments on the science then available on Depo-Provera.

“Of course,” said Kline, “It was and is very difficult to separate science from the society that produced it. There was a reason, given the understood risks of Depo-Provera, that its testing was done on poor women in the U.S. and on women in developing countries.”

Still, at the Depo-Provera hearings of 1983, those against the use of Depo-Provera were able to introduce the concept that the FDA’s established cost/benefit analysis of a drug should include quality of life issues and that dismissing female patient’s complaints about crippling side effects was not just “sexist,” it was bad science.

Another outcome of the FDA 1983 inquiry into Depo-Provera and the publicity surrounding the hearings was the first national conference on black women’s health held in Atlanta in 1983.

The larger message, according to Kline, is that eugenics is more than simply an embarrassing mistake of the past. The popular belief that technology and regulation of sexual fertility would lead to healthier, stronger, more self-reliant population carried over in the 1970s, ‘80s and even today.

Kline's research was funded by a Harvard University Countway Library of Medicine, a Summer Research Fellowship from the Charles Phelps Taft Research Center at UC and a UC Research Council Grant.

M.B. Reilly | EurekAlert!
Further information:
http://www.uc.edu

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Excitation of robust materials

Kiel physics team observed extremely fast electronic changes in real time in a special material class

In physics, they are currently the subject of intensive research; in electronics, they could enable completely new functions. So-called topological materials...

Im Focus: Electrons in the fast lane

Solar cells based on perovskite compounds could soon make electricity generation from sunlight even more efficient and cheaper. The laboratory efficiency of these perovskite solar cells already exceeds that of the well-known silicon solar cells. An international team led by Stefan Weber from the Max Planck Institute for Polymer Research (MPI-P) in Mainz has found microscopic structures in perovskite crystals that can guide the charge transport in the solar cell. Clever alignment of these "electron highways" could make perovskite solar cells even more powerful.

Solar cells convert sunlight into electricity. During this process, the electrons of the material inside the cell absorb the energy of the light....

Im Focus: The lightest electromagnetic shielding material in the world

Empa researchers have succeeded in applying aerogels to microelectronics: Aerogels based on cellulose nanofibers can effectively shield electromagnetic radiation over a wide frequency range – and they are unrivalled in terms of weight.

Electric motors and electronic devices generate electromagnetic fields that sometimes have to be shielded in order not to affect neighboring electronic...

Im Focus: Gentle wall contact – the right scenario for a fusion power plant

Quasi-continuous power exhaust developed as a wall-friendly method on ASDEX Upgrade

A promising operating mode for the plasma of a future power plant has been developed at the ASDEX Upgrade fusion device at Max Planck Institute for Plasma...

Im Focus: ILA Goes Digital – Automation & Production Technology for Adaptable Aircraft Production

Live event – July 1, 2020 - 11:00 to 11:45 (CET)
"Automation in Aerospace Industry @ Fraunhofer IFAM"

The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM l Stade is presenting its forward-looking R&D portfolio for the first time at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Contact Tracing Apps against COVID-19: German National Academy Leopoldina hosts international virtual panel discussion

07.07.2020 | Event News

International conference QuApps shows status quo of quantum technology

02.07.2020 | Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

 
Latest News

On-chip spin-Hall nanograting for simultaneously detecting phase and polarization singularities

08.07.2020 | Physics and Astronomy

Engineers use electricity to clean up toxic water

08.07.2020 | Agricultural and Forestry Science

Atomic 'Swiss army knife' precisely measures materials for quantum computers

08.07.2020 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>